Concepedia
Statistics
Publications
3
Citations
70
H-Index
Active since
2017
Affiliations
Tel Aviv University(Current)
Meir Medical Center
Hadassah Medical Center
Adi Alfandari is an author at Tel Aviv University specializing in molecular oncology, ovarian cancer, and oncology.
Publications per year
2017–2021
The Interplay Between Epithelial-Mesenchymal Transition (EMT) and the Thyroid Hormones-αvβ3 Axis in Ovarian Cancer
C Weingarten, Yonatan Jenudi, Rami Yair Tshuva et al. · Hormones and Cancer · 2017 · 35 citations · Full text
Medicine, Molecular Biology, Oncology +16
DIO3, the thyroid hormone inactivating enzyme, promotes tumorigenesis and metabolic reprogramming in high grade serous ovarian cancer
Dotan Moskovich, Adi Alfandari, Yael Finkelshtein et al. · Cancer Letters · 2020 · 18 citations
Medicine, Gynecology, Oncology +16
Targeting the DIO3 enzyme using first-in-class inhibitors effectively suppresses tumor growth: a new paradigm in ovarian cancer treatment
Dotan Moskovich, Yael Finkelshtein, Adi Alfandari et al. · Oncogene · 2021 · 17 citations · Full text
Medicine, Oncology, Pharmacology +17
1–3 of 3